Skip to content
10-K

Annual Report

Fibrocell Science, Inc.

0001628280-19-003496

← back to feed
Filed
Mar 27, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Mar 20, 2019 9.76M sh
Shares Diluted FY 2018 · Dec 31, 2018 7.69M sh
Shares Diluted restated FY 2018 · Dec 31, 2017 3.09M sh
Capex FY 2018 · Dec 31, 2018 $164K
Capex FY 2018 · Dec 31, 2017 $433K
Operating Cash Flow FY 2018 · Dec 31, 2018 −$12.72M
Operating Cash Flow FY 2018 · Dec 31, 2017 −$17.04M
Cash And Equivalents FY 2018 · Dec 31, 2018 $14.43M
Cash And Equivalents FY 2018 · Dec 31, 2017 $17.42M
Cash And Equivalents FY 2018 · Dec 31, 2016 $17.52M
Stockholders Equity FY 2018 · Dec 31, 2018 $9.56M
Stockholders Equity FY 2018 · Dec 31, 2017 $9.01M
Stockholders Equity FY 2018 · Dec 31, 2016 $7.86M
Current Liabilities FY 2018 · Dec 31, 2018 $2.17M
Current Liabilities FY 2018 · Dec 31, 2017 $4.43M
Total Liabilities FY 2018 · Dec 31, 2018 $6.2M
Total Liabilities FY 2018 · Dec 31, 2017 $10.4M
Current Assets FY 2018 · Dec 31, 2018 $14.54M
Current Assets FY 2018 · Dec 31, 2017 $17.9M
Total Assets FY 2018 · Dec 31, 2018 $15.76M
Total Assets FY 2018 · Dec 31, 2017 $19.41M
Eps Diluted FY 2018 · Dec 31, 2018 −$1.45
Eps Diluted restated FY 2018 · Dec 31, 2017 −$6.67
Eps Basic FY 2018 · Dec 31, 2018 −$1.45
Eps Basic restated FY 2018 · Dec 31, 2017 −$6.66
Sga Expense FY 2018 · Dec 31, 2018 $6.41M
Sga Expense FY 2018 · Dec 31, 2017 $6.75M
Rd Expense FY 2018 · Dec 31, 2018 $6.02M
Rd Expense FY 2018 · Dec 31, 2017 $6.51M
Net Income FY 2018 · Dec 31, 2018 −$10.28M
Net Income FY 2018 · Dec 31, 2017 −$16.24M
Operating Income FY 2018 · Dec 31, 2018 −$12.39M
Operating Income FY 2018 · Dec 31, 2017 −$18.98M
Revenue FY 2018 · Dec 31, 2018 $0
Revenue FY 2018 · Dec 31, 2017 $0